Phenotype of CD34+ stem cell subpopulations in peripheral blood of patients undergoing mobilization of PBSC with cyclophosphamide, etoposide and SC-70935 or G-CSF

被引：0
|
作者：
Klabusay, M
Lysak, D
Kovarova, L
Koristek, Z
Mayer, J
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S253 / S253
页数：1
相关论文
共 50 条
  • [11] Comparison of G-CSF and GM-CSF in combination with chemotherapy for peripheral blood stem cell (PBSC) mobilization.
    Bojko, P
    Waschek, S
    Seeber, S
    Nowrousian, MR
    BLOOD, 2001, 98 (11) : 177A - 177A
  • [12] COMPARISON OF HIGH AND INTERMEDIATE DOSE ETOPOSIDE WITH G-CSF PRIMING FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION
    Buyukkurt, N.
    Yeral, M.
    Kozanoglu, I.
    Kasar, M.
    Unver, G.
    Boga, C.
    Ozdogu, H.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S528 - S528
  • [13] COMPARISON OF HIGH-DOSE CYCLOPHOSPHAMIDE PLUS G-CSF WITH G-CSF ALONE FOR PERIPHERAL BLOOD STEM CELL MOBILIZATION IN MM
    Jang, J. E.
    Hyun, S. Y.
    Hwang, D. Y.
    Yoon, S. H.
    Kim, Y. D.
    Kim, S. J.
    Kim, J. S.
    Cheong, J. -W.
    Min, Y. H.
    ANNALS OF ONCOLOGY, 2012, 23 : 83 - 83
  • [14] Endogenous chemokine production after G-CSF induced peripheral blood stem cell (PBSC) mobilization.
    Engelhardt, M
    Guo, Y
    Nauck, M
    Wäsch, R
    Schwabe, M
    Bertz, H
    Finke, J
    BLOOD, 1999, 94 (10) : 147B - 147B
  • [15] Leridistim vs. G-CSF mobilization of peripheral blood stem cells when used with cyclophosphamide and etoposide in patients with lymphoma.
    Mayer, J
    Indrak, K
    Koza, V
    Lazarus, H
    Shea, T
    Peppard, TE
    Helland, JA
    Needle, M
    Baum, CM
    BLOOD, 2000, 96 (11) : 181A - 181A
  • [16] Normal CD34+ peripheral blood stem cells (PBSC) can be mobilized by in vivo treatment with G-CSF in paroxysmal nocturnal hemoglobinuria (PNH).
    Musto, P
    DArena, G
    Cascavilla, N
    Carotenuto, M
    BLOOD, 1996, 88 (10) : 1207 - 1207
  • [17] Successful peripheral blood mobilization of CD34 progenitor cells by cyclophosphamide, paclitaxel and G-CSF after failure with G-CSF alone.
    Dansey, R
    Klein, J
    Karanes, C
    Akhtar, A
    Cassells, L
    Peters, WP
    Baynes, RD
    BLOOD, 1997, 90 (10) : 428 - 428
  • [18] Plerixafor and G-CSF Versus Cyclophosphamide and G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma
    Nazha, Aziz
    Cook, Rachel
    Vogl, Dan T.
    Mangan, Patricia A.
    Hummel, Kimberly
    Cunningham, Kathleen
    Luger, Selina
    Porter, David
    Schuster, Stephen J.
    O'Doherty, Una
    Sell, Mary
    Siegel, Don L.
    Stadtmauer, Edward A.
    BLOOD, 2009, 114 (22) : 844 - 844
  • [19] Prospective, randomized study of peripheral blood stem cell (PBSC) mobilization with daniplestim G-CSF versus placebo plus G-CSf in breast cancer patients.
    DiPersio, JF
    Vredenburg, J
    Copelan, EA
    Prosper, F
    Sola, C
    Lill, M
    Bolwell, BJ
    Santos, VR
    Collins, DM
    Baum, CM
    BLOOD, 1998, 92 (10) : 269A - 269A
  • [20] Randomized mobilization of CD34+ peripheral stem cells by G-CSF compared to G+GM-CSF (half dose) after cyclophosphamide (4 g/m2)
    Quittet, P
    Legouffe, E
    Lopez, E
    Fegueux, N
    Klein, B
    Rossi, JF
    BLOOD, 1998, 92 (10) : 272A - 272A
12345